Exchange Announcement • 27 Oct 2022 18:00
Q3 2022
Exchange Announcement • 19 Jul 2022 19:00
Q2 2022
Exchange Announcement • 28 Apr 2022 19:37
Q1 2022
Exchange Announcement • 10 Feb 2022 08:00
Q4 2021
Exchange Announcement • 22 Oct 2021 08:00
𝛼SK or SearchENTITY
Swedish Orphan Biovitrum AB (SOBI SS)
Swedish Orphan Biovitrum AB (SOBI SS)
9
Analysis
Health Care • Sweden
Swedish Orphan Biovitrum AB (SOBI) operates as a bio-pharmaceutical and bio-technology company. The Company develops therapies and drugs for the treatment of haemophilia, inflammation, and genetic diseases. SOBI serves clients worldwide.
morex